Rockefeller Capital Management
FLNA

Rockefeller Capital Management’s Filana Therapeutics FLNA Stock Holding History

Rockefeller Capital Management’s Portfolio FLNA Stock Details FLNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-5
Closed -$10 – 4853
2025
Q4 		$10 Hold
5
– – ﹤0.01% 4659
2025
Q3 		$15 Buy
+5
New +$11 ﹤0.01% 4410
2023
Q1 		– Sell
-6,298
Closed -$185K – 3549
2022
Q4 		$185K Buy
6,298
+23
+0.4% +$827 ﹤0.01% 1704
2022
Q3 		$262K Buy
6,275
+5,000
+392% +$135K ﹤0.01% 1534
2022
Q2 		$35K Hold
1,275
– – ﹤0.01% 2451
2022
Q1 		$47K Sell
1,275
-37
-3% -$1.57K ﹤0.01% 2332
2021
Q4 		$56K Buy
1,312
+37
+3% +$1.94K ﹤0.01% 2168
2021
Q3 		$79K Buy
+1,275
New +$106K ﹤0.01% 1962

Other funds holding FLNA

Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
GC
GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

Rockefeller Capital Management's FLNA Position: Q1 2026 in Review

Rockefeller Capital Management sold out of Filana Therapeutics (FLNA) in Q1 2026, closing a stake of 5 shares — an estimated $10 sold.

Rockefeller Capital Management first reported a position in FLNA in Q3 2021 and held it in 8 quarters. The position peaked at $262K in Q3 2022. 101 funds tracked by Wall St. Rank hold FLNA as of Q1 2026.

  • Rockefeller Capital Management reported no remaining Filana Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Rockefeller Capital Management sold 5 Filana Therapeutics shares in Q1 2026, an estimated $10.
  • Rockefeller Capital Management first reported a position in Filana Therapeutics in Q3 2021 and held it in 8 quarters.
  • Rockefeller Capital Management's Filana Therapeutics position peaked at $262K in Q3 2022.
  • 101 funds tracked by Wall St. Rank held Filana Therapeutics as of Q1 2026.

Based on Rockefeller Capital Management's 13F filing for Q1 2026, filed 14 May 2026.